Bowel cancer treatment can come with fertility risks and understanding the preservation options available is an important consideration for many bowel cancer patients.
Just as all other side effects are discussed, possible impacts on fertility should be part of any discussions with your treating specialist before starting treatment for bowel cancer.
Diagnosed with stage 4 bowel cancer and secondary liver cancer at the age of 24, Hollie Fielder was told she had a 5% chance to be alive in 5 years. But in an inspiring story of ‘beating the odds’ - after two major operations on her bowel and liver, and six months of chemotherapy, Hollie was given the all clear.
Shortly after her diagnosis, Hollie made contact with Bowel Cancer Australia, and she has been a passionate Awareness Advocate ever since.
For around 30% of all bowel cancer cases diagnosed there is a family history, hereditary contribution or a combination of both.
It is a disease that affects men and women of all ages, and its impact is felt not just by those diagnosed with the disease, but also by their loved ones.
A new grant secured by the Lawrence Penn Chair of Bowel Cancer Research laboratory from the Cancer Institute NSW will enable further investigation into the prognostic contribution of immune cell infiltration in rectal cancer.
Bowel cancer is the second most commonly diagnosed cancer in Aussie women, claiming the lives of almost 2,500 wives, mothers, sisters, daughters, aunts, nieces and girlfriends in Australia every year.